Literature DB >> 27317567

LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation.

Pengfei Zhang1, Limian Cao1, Pingsheng Fan2, Yide Mei1, Mian Wu3.   

Abstract

The c-Myc proto-oncogene is activated in more than half of all human cancers. However, the precise regulation of c-Myc protein stability is unknown. Here, we show that the lncRNA-MIF (c-Myc inhibitory factor), a c-Myc-induced long non-coding RNA, is a competing endogenous RNA for miR-586 and attenuates the inhibitory effect of miR-586 on Fbxw7, an E3 ligase for c-Myc, leading to increased Fbxw7 expression and subsequent c-Myc degradation. Our data reveal the existence of a feedback loop between c-Myc and lncRNA-MIF, through which c-Myc protein stability is finely controlled. Additionally, we show that the lncRNA-MIF inhibits aerobic glycolysis and tumorigenesis by suppressing c-Myc and miR-586.
© 2016 The Authors.

Entities:  

Keywords:  Fbxw7; c‐Myc; glycolysis; lncRNA; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27317567      PMCID: PMC4967955          DOI: 10.15252/embr.201642067

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  52 in total

1.  Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.

Authors:  Taewan Kim; Young-Jun Jeon; Ri Cui; Ji-Hoon Lee; Yong Peng; Sung-Hak Kim; Esmerina Tili; Hansjuerg Alder; Carlo M Croce
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

Review 2.  The Myc oncoprotein as a therapeutic target for human cancer.

Authors:  Marina Vita; Marie Henriksson
Journal:  Semin Cancer Biol       Date:  2006-08-03       Impact factor: 15.707

3.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 4.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

5.  The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

Authors:  Dalia Barsyte-Lovejoy; Suzanne K Lau; Paul C Boutros; Fereshteh Khosravi; Igor Jurisica; Irene L Andrulis; Ming S Tsao; Linda Z Penn
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.

Authors:  K Bhatia; K Huppi; G Spangler; D Siwarski; R Iyer; I Magrath
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

7.  Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

Authors:  Meaghan Wall; Gretchen Poortinga; Katherine M Hannan; Richard B Pearson; Ross D Hannan; Grant A McArthur
Journal:  Blood       Date:  2008-07-11       Impact factor: 22.113

Review 8.  The c-myc promoter: still MysterY and challenge.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.

Authors:  H M Clark; T Yano; T Otsuki; E S Jaffe; D Shibata; M Raffeld
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

10.  The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.

Authors:  Thomas Derrien; Rory Johnson; Giovanni Bussotti; Andrea Tanzer; Sarah Djebali; Hagen Tilgner; Gregory Guernec; David Martin; Angelika Merkel; David G Knowles; Julien Lagarde; Lavanya Veeravalli; Xiaoan Ruan; Yijun Ruan; Timo Lassmann; Piero Carninci; James B Brown; Leonard Lipovich; Jose M Gonzalez; Mark Thomas; Carrie A Davis; Ramin Shiekhattar; Thomas R Gingeras; Tim J Hubbard; Cedric Notredame; Jennifer Harrow; Roderic Guigó
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

View more
  41 in total

1.  Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140.

Authors:  Yuqin Ding; Qianjin Fang; Yan Li; Yanni Wang
Journal:  Mamm Genome       Date:  2019-06-20       Impact factor: 2.957

2.  Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Guang Zhang; Jingxin Li; Xianning Wu; Xiaoling Ma; Ge Shan; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

3.  c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53.

Authors:  Pei Zhu; Yan Li; Ping Li; Yuying Zhang; Xiaowei Wang
Journal:  Mol Genet Genomics       Date:  2019-05-14       Impact factor: 3.291

4.  Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis.

Authors:  Yong Liu; Yaqing Chen; Lili Tan; Hongmei Zhao; Nuan Xiao
Journal:  Heart Vessels       Date:  2019-02-08       Impact factor: 2.037

5.  ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs.

Authors:  Xiaolu Cui; Chiyuan Piao; Chengcheng Lv; Xuyong Lin; Zhe Zhang; Xiankui Liu
Journal:  Cell Mol Life Sci       Date:  2019-07-18       Impact factor: 9.261

6.  MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer.

Authors:  Jingli Wu; Yuying Zhao; Fenglian Li; Baohua Qiao
Journal:  J Physiol Biochem       Date:  2019-04-23       Impact factor: 4.158

Review 7.  Perspectives of long non-coding RNAs in cancer.

Authors:  Arunagiri Kuha Deva Magendhra Rao; Thangarajan Rajkumar; Samson Mani
Journal:  Mol Biol Rep       Date:  2017-04-08       Impact factor: 2.316

Review 8.  LncRNA-ATB: An indispensable cancer-related long noncoding RNA.

Authors:  Jinglin Li; Zhenglong Li; Wangyang Zheng; Xinheng Li; Zhidong Wang; Yunfu Cui; Xingming Jiang
Journal:  Cell Prolif       Date:  2017-09-08       Impact factor: 6.831

9.  GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH.

Authors:  Rui Yang; Na Liu; Ling Chen; Yiqun Jiang; Ying Shi; Chao Mao; Yating Liu; Min Wang; Weiwei Lai; Haosheng Tang; Menghui Gao; Desheng Xiao; Xiang Wang; Hu Zhou; Can-E Tang; Wenliang Liu; Fenglei Yu; Ya Cao; Qin Yan; Shuang Liu; Yongguang Tao
Journal:  Oncogene       Date:  2019-08-15       Impact factor: 9.867

10.  LncRNA GUARDIN suppresses cellular senescence through a LRP130-PGC1α-FOXO4-p21-dependent signaling axis.

Authors:  Xuedan Sun; Rick Francis Thorne; Xu Dong Zhang; Miao He; Jinming Li; Shanshan Feng; Xiaoying Liu; Mian Wu
Journal:  EMBO Rep       Date:  2020-03-09       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.